Ep104: Jeff Bluestone on Treg Cell Therapies for Autoimmunity - a podcast by Timmerman Report
from 2021-12-01T17:47:42
::
::
Jeff Bluestone, CEO of Sonoma Biotherapeutics, on engineered T-reg cell therapies for autoimmunity.
Further episodes of The Long Run with Luke Timmerman
Further podcasts by Timmerman Report
Website of Timmerman Report